Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. According to the World Health Organization, cancer is a leading cause of death and accounted for 7.6 million deaths (around 13% of all deaths) in 2008. This number is expected to rise to 12 million by 2030[@b1]. The increase in cancer deaths is signaling the pressing need for newer, even more effective diagnostics and therapies. Recently, "theranostics", which incorporate both therapy and diagnosis, are attracting significant attention[@b2]. The integration of diagnostic imaging capability with therapeutic interventions is critical in addressing the challenges of cancer heterogeneity and adaptation. Therefore, theranostic agents have attracted enormous interest in cancer diagnosis and treatment in recent years.

Albeit substantial progress was accomplished, conventional diagnostic and therapeutic agents, such as iodinated contrast agent, radio-labeled biomolecules, or chemotherapy drugs, are often limited by short blood circulation times and nonspecific biodistribution[@b3]. The emergence of nanomaterials offers new opportunities for advanced diagnostics and therapeutics. Nanomaterials provide several potential advantages over conventional agents, including extension of circulating half-life, passive accumulation at tumor sites due to the enhanced permeability and retention (EPR) effect, reduced toxicity and integration of multiple diverse functions in a single complex[@b3]. Up to now, several nanomaterials have acted as nanotheranostic agents[@b4][@b5][@b6][@b7], such as magnetic nanoparticles[@b8][@b9][@b10], carbon nanotubes[@b11][@b12], gold-based nanostructures[@b13][@b14][@b15] and nanoshells-based nanoparticles[@b3][@b16]. Although impressive advances have been made in nanotheranostic agents, the types of nanomaterials with efficient diagnostic imaging and therapeutic capabilities simultaneously are limited. Therefore, there is still a great demand for developing new nanomaterials for the diagnosis and treatment of different cancers.

Topological insulators are a new class of quantum matter for which their bulk phases are ordinary insulators but possess robust, nontrivial, and conducting surface or boundary states with nondegenerate spins[@b17]. Beyond the inherent importance of exploring complex phases of quantum matter, topological insulators are of great interest for device applications involving quantum computing and photonics. For their special characteristics, topological insulators have become the rising star in physics and provided challenges and opportunities for chemistry and material science[@b18]. Bismuth selenide (Bi~2~Se~3~) is theoretically predicted and experimentally observed to be a three-dimensional (3D) topological insulator with a single Dirac cone[@b19]. Bi~2~Se~3~ has attracted great attention in physics and chemistry because of its remarkable thermoelectric[@b20], optical[@b21] and photoelectric properties[@b22]. Although, the synthesis and investigation of the physical properties of Bi~2~Se~3~ have been undertaken, little has been done to explore Bi~2~Se~3~ in biomedical fields. Bi~2~Se~3~ is composed of bismuth (Bi) and selenium (Se). Bi is an environmentally friendly element and has a long history of use as a therapeutic agent with low toxicity[@b23]. Furthermore, Bi is an attractive element for X-ray contrast agents due to its high atomic number (Z = 83) and well-known biological tolerance[@b24]. Recently, some Bi-based nanomaterials have been explored as high contrast, long-circulating, low-toxicity X-ray contrast agents[@b25][@b26][@b27]. The other component is Se, which is an essential trace element for human. The recommended dietary allowance of Se is 55 μg per day for healthy human adults[@b28]. Meanwhile, Se also plays important biological roles through the selenoproteins, which helps protect tissues and membranes from oxidative stress and controls cell redox status[@b29]. In addition, accumulating evidence indicates that Se has benefits in reducing the risk of cancer incidence and mortality in many cancer types, and specifically in liver, prostate and lung cancers[@b30]. Therefore, Bi~2~Se~3~ is presumed to be biocompatible and holds great potential in biomedical fields.

Here we investigate the theranostic properties of Bi~2~Se~3~ nanoplates in *in vivo* and *in vitro* system for the first time ([Fig. 1](#f1){ref-type="fig"}). We show that Bi~2~Se~3~ nanoplates can absorb NIR laser light and effectively convert laser energy into heat. The photothermal conversion properties of topological insulators have not been reported so far, although many excellent physical properties of topological insulators have been extensively investigated. Besides, Bi~2~Se~3~ nanoplates also exhibit strong X-ray attenuation for in vivo X-ray computed tomography (CT) imaging. Therefore, topological insulator Bi~2~Se~3~ holds promise as a novel theranostic platform.

Results
=======

Synthesis and characterization of Bi~2~Se~3~ nanoplates
-------------------------------------------------------

Bi~2~Se~3~ nanoplates were prepared by a simple synthetic route and coated with polyvinylpyrrolidone (PVP)[@b31]. PVP is a biodegradable and water-soluble biocompatible polymer and is frequently employed as binding, dispersing and stabilizing agent in pharmaceutical tablets and injectables[@b32]. Moreover, PVP has also been used to stabilize a variety of nanoparticles to expand their biological applicability[@b25][@b33][@b34]. The synthesized Bi~2~Se~3~ nanoplates showed relatively uniform sizes with an average diameter of about 90 nm ([Fig. 2a](#f2){ref-type="fig"}) based on transmission electron microscope (TEM) images. In addition, the as-prepared Bi~2~Se~3~ has a layered structure based on AFM analysis. The thickness of the outer layer was about 3.9 nm and inner layer was about 21.5 nm ([Supplementary Fig. S1](#s1){ref-type="supplementary-material"}). The phase analysis of the as-prepared product was determined by powder X-ray diffraction (XRD) ([Fig. 2b](#f2){ref-type="fig"}). All peaks in the pattern correspond to the reflections of the rhombohedral phase of Bi~2~Se~3~, which match well with the reported value (JCPDS Card No. 33-0214)[@b31]. Furthermore, Bi~2~Se~3~ nanoplates exhibited good dispersion in a range of physiological solutions including saline, cell medium, and serum ([Supplementary Fig. S2](#s1){ref-type="supplementary-material"}).

Cytotoxicity and cell internalization of Bi~2~Se~3~ nanoplates
--------------------------------------------------------------

Prior to using Bi~2~Se~3~ nanoplates for in vivo imaging and therapy, we tested their cell cytotoxicity using the methyl thiazolyl tetrazolium (MTT) assay at first. Encouragingly, cell viability was not hindered by Bi~2~Se~3~ nanoplates up to a concentration of 200 μg ml^−1^ ([Fig. 3a](#f3){ref-type="fig"}). The results suggest that Bi~2~Se~3~ nanoplates possess low cell cytotoxicity and good biocompatibility. To study the mechanism of the cellular uptake of Bi~2~Se~3~ nanoplates, we incubated the H22 cells with Bi~2~Se~3~ nanoplates at 4°C and 37°C, respectively. The uptake efficiency of Bi~2~Se~3~ nanoplates was investigated using inductively coupled plasma mass spectrometry (ICP-MS). The results shown in [Fig. 3b](#f3){ref-type="fig"} reveal that the cellular uptake of Bi~2~Se~3~ nanoplates is significantly decreased at 4°C. This result implies cellular uptake of Bi~2~Se~3~ nanoplates is through an energy-dependent endocytosis[@b35].

In vitro and in vivo X-ray computed tomography (CT) imaging
-----------------------------------------------------------

Bi~2~Se~3~ nanoplates hold great promise for CT contrast agents because Bi possesses the large X-ray attenuation coefficient (Bi: 5.74, Au: 5.16, Pt: 4.99, Ta: 4.3 and I: 1.94 cm^2^kg^−1^ at 100 keV). In this work, the Hounsfield Units (HU) of Bi~2~Se~3~ nanoplates was evaluated by a clinical CT. [Figure 4a](#f4){ref-type="fig"} displays the CT images in the range from 0 to 0.0488 mol Bi l^−1^ of Bi~2~Se~3~ nanoplates. It can be observed that CT signal intensity continuously increases with the increasing of Bi~2~Se~3~ nanoplates concentrations, resulting in brighter images. To further investigate the CT contrast efficacy, we next compared the X-ray absorption of Bi~2~Se~3~ to that of Iopamidol in vitro ([Fig. 4a](#f4){ref-type="fig"}). Iopamidol is one of most widely used CT contrast agents in current clinical applications. The results demonstrate that Bi~2~Se~3~ produces higher contrast than Iopamidol. The HU values increase linearly with concentration for both Bi~2~Se~3~ and Iopamidol ([Fig. 4b](#f4){ref-type="fig"}). Nevertheless, the HU values of Bi~2~Se~3~ are higher than that of Iopamidol at equivalent concentrations due to the fact that the attenuation coefficient of Bi is larger than that of iodine (I). Thus, Bi~2~Se~3~ provides an equivalent contrast at a lower dose compared to the clinical iodinate agent. The reduced dose is highly beneficial because it reduces potential side effects and complications in clinical applications. Furthermore, in vitro CT imaging of H22 cells incubated with different concentrations of Bi~2~Se~3~ nanoplates was also investigated. [Figure 4a](#f4){ref-type="fig"} (last row) shows the transection CT images of H22 cells with or without incubation of the Bi~2~Se~3~ nanoplates. It is clear that with the incubated concentration of Bi~2~Se~3~ nanoplates increasing, H22 cells gradually display brighter CT images.

The excellent in vitro performance of Bi~2~Se~3~ nanoplates as a potential CT imaging agent encouraged us to pursue their applicability in CT imaging in vivo. The feasibility of Bi~2~Se~3~ nanoplates as CT contrast agents in vivo was demonstrated by intratumoral injection of Bi~2~Se~3~ nanoplates. [Figure 4c](#f4){ref-type="fig"} shows the tumor CT images before and after intratumoral injection. The subcutaneous injection site displays a brighter CT signal than other soft tissues, which is attributed to the strong X-ray attenuation induced by Bi. After analysis of the CT values of the tumor area at 30 min and 120 min post-injection, we found that the CT value decreased slightly (627 ± 22.8 versus 545 ± 13.6). It is because with the passage of time, Bi~2~Se~3~ nanoplates could diffuse in the tumor. Therefore, the CT values of the tumor area would decrease gradually. However, the CT value of tumor area even at 120 min post-injection was still significantly higher than that of the tumor area before injection (545 ± 13.6 versus 85 ± 5.2). As control, the mice were injected with Iopamidol at the central region of the tumor under similar conditions. The inject region showed a white spot with brightness lower than the case of Bi~2~Se~3~ nanoplates ([Supplementary Fig. S3](#s1){ref-type="supplementary-material"}). These results provide strong evidence that Bi~2~Se~3~ may be a promising contrast agent for CT imaging in future clinical applications.

In vitro and in vivo photothermal therapy
-----------------------------------------

Photothermal therapy (PTT) is a hyperthermia therapeutic approach that employs photoabsorbing agents to burn cancer cells by heat generated from optical energy[@b36]. Deep penetration and little nonspecific photothermal heating in the near-infrared (NIR) window are due to the transparency and low absorption of light by tissues in this optical window[@b37]. Compared with traditional cancer therapies such as radiotherapy and chemotherapy, PTT cancer treatment is a minimally invasive or noninvasive technique. In recent years, some NIR light absorbing nanomaterials have been developed for PTT. At present, there are four main types of NIR laser-driven photothermal agents have been extensively developed, resulting in great contributions to progress in PTT. The first type is organic compounds[@b38][@b39][@b40][@b41]. The second type is carbon-based materials, including carbon nanotubes[@b42][@b43][@b44][@b45] and graphene[@b46][@b47][@b48]. The third type is metal nanostructures, such as Au nanostructures[@b13][@b14][@b15], palladium nanosheets[@b49] and chemically exfoliated MoS~2~[@b50]. The last type is copper chalcogenide semiconductors[@b51][@b52][@b53][@b54]. As far as we know, the photothermal conversion properties of topological insulators have not been reported so far.

In this work, we demonstrate the Bi~2~Se~3~ nanoplates display high optical absorption in the NIR range ([Supplementary Fig. S4](#s1){ref-type="supplementary-material"}). And they can effectively convert NIR laser radiation into heat. We examined the temperature increase of Bi~2~Se~3~ nanoplates aqueous solution with various concentrations by the 808 nm laser ([Fig. 5a](#f5){ref-type="fig"}). The temperature of the Bi~2~Se~3~ nanoplates solution increased rapidly, while pure water showed a negligible change. The temperature of the solution containing 50 μg ml^−1^ Bi~2~Se~3~ nanoplates rose from 24.4°C to 50.2°C after 5 min irradiation. We presume that this highly efficient photothermal conversion property may be due to the unique physical properties of topological insulators.

Next, we evaluated in vitro photothermal ablation capacity of Bi~2~Se~3~ nanoplates with H22 cells. The MTT results showed that H22 cells treated with Bi~2~Se~3~ nanoplates without laser irradiation remain more than 90% viable at Bi~2~Se~3~ nanoplates concentrations up to 50 μg ml^−1^. The cell viability significantly decreased when they were simultaneously treated with Bi~2~Se~3~ nanoplates and laser irradiation. And only about 25% of H22 cells remained viable at a Bi~2~Se~3~ nanoplates concentration of 50 μg ml^−1^ ([Fig. 5b](#f5){ref-type="fig"}).

After confirming the photothermal effect of Bi~2~Se~3~ nanoplates, we attempted in vivo therapeutic examinations against Balb/c mice bearing H22 cancer tumors. After the tumor sizes became approximately 100 mm^3^, the mice were divided into four groups (n = 7): (a) sterile water; (b) sterile water + laser; (c) Bi~2~Se~3~ nanoplates; (d) Bi~2~Se~3~ nanoplates + laser. For group (d), each mouse was treated with an intratumoral injection of Bi~2~Se~3~ nanoplates followed by NIR irradiation. One noticeable observation is that there were small black round marks on the skin after treatment. This black mark is a skin burn scar which is a direct evidence of the generation of excessive local heating from Bi~2~Se~3~ nanoplates by NIR. Under the same irradiation conditions, in contrast, there was no noticeable sign of temperature increase in the mice treated with sterile water followed by NIR irradiation (group b). Another two control groups (a and c) of mice with sterile water or Bi~2~Se~3~ nanoplates injection were not irradiated.

Tumor sizes were measured every 2 days after the above treatments. [Figure 5c](#f5){ref-type="fig"} shows tumor volume changes of representative mice treated in different groups as a function of time. Tumors that received only Bi~2~Se~3~ nanoplates injection (group c) or laser irradiation (group b) showed growth rates indistinguishable from control tumors (group a). This result demonstrated that only NIR laser irradiation or Bi~2~Se~3~ nanoplates injection did not affect the tumor development. In marked contrast, tumors of group (d) were completely eliminated one day after treatment, leaving the original tumor site with black scars which fell off about 1 week later ([Fig. 5d](#f5){ref-type="fig"}). In addition, NIR at power density of 2 W/cm^2^ alone did not cause damage to cancer tissues ([Supplementary Fig. S5](#s1){ref-type="supplementary-material"}). No tumor regrowth was noted in this treated group over a course of 45 days, after which the study was ended. In addition, the toxicity of the as-prepared Bi~2~Se~3~ nanoplates was examined in vivo. We did not find any obvious sign of toxic side effects for Bi~2~Se~3~ nanoplates injected mice within 45 days. Neither death nor significant body weight drop was observed in all experimental groups ([Supplementary Fig. S6](#s1){ref-type="supplementary-material"}). Furthermore, major organs of Bi~2~Se~3~ nanoparticles + laser treated mice (group d) whose tumors were eliminated by the photothermal therapy were collected 45 days after the treatment for histology analysis. No evident tissue damage from the group (d) compared to the control group (a) ([Supplementary Fig. S7](#s1){ref-type="supplementary-material"}). Our results suggest that Bi~2~Se~3~ nanoplates may be a powerful agent for in vivo photothermal cancer therapy.

Discussion
==========

The development of new nanomaterials for simultaneous cancer diagnosis and treatment has been receiving great attention in recent years and has now become an important field in medical research. Bi~2~Se~3~, as a three-dimensional topological insulator, causes wide attention recently. It has been proved that Bi~2~Se~3~ has many excellent physical properties, such as thermoelectricity and photoelectricity. In present work, we investigate the theranostic properties of Bi~2~Se~3~ nanoplates in *in vivo* and *in vitro* system. We prove that Bi~2~Se~3~ nanoplates have the X-ray CT imaging and photothermal therapeutic capabilities simultaneously. On one hand, as an X-ray contrast agent, Bi~2~Se~3~ nanoplates provide higher contrast efficacy than a clinical iodinate agent. The xenograft tumor model could be imaged using CT after intratumoral administration of Bi~2~Se~3~ nanoplates. On the other hand, as a photothermal therapeutic agent, Bi~2~Se~3~ nanoplates can absorb NIR laser and effectively transfer laser energy into heat, then successfully induce complete eradications of solid malignant tumors in mice by hyperthermia. More importantly, the photothermally treated mice were all healthy without toxic effects, abnormal behavior, or recurrence of tumors over a long period of time. Our results clearly indicate that Bi~2~Se~3~ nanoplates may be a promising platform for simultaneous diagnosis and therapy, and bring novel opportunities in theranostics.

Furthermore, bismuth complexes and selenium complexes have a long history of use as therapeutic agents with low toxicity. In addition, Se has benefits in reducing the risk of cancer incidence and mortality in many cancer types. Therefore, Bi~2~Se~3~ is presumed to be biocompatible. In our preliminary experiments, the results also prove that Bi~2~Se~3~ nanoplates have a low toxicity to cells and no observable toxicity in mice.

Although potential applications of Bi~2~Se~3~ in biomedical fields are shown in this paper, a number of issues demand clarification and further researches. Potential toxicity, the long-term biodistribution and quantitative pharmacokinetics in vivo are extremely important and need to be addressed. On the other hand, the incorporation of tumor targeting ligands with Bi~2~Se~3~ to achieve active targeting is another interesting issue. These works are underway now in our laboratory and will be communicated in due course.

Methods
=======

Synthetic procedure and characterization of Bi~2~Se~3~ nanoplates
-----------------------------------------------------------------

The Bi~2~Se~3~ nanoplates were synthesized according to the method published previously[@b31]. In brief, A reaction batch (100 ml two-neck round-bottom flask) contained ethylene glycol (40 ml), Na~2~SeO~3~ (99%, Aldrich, 0.06 g), Bi(NO~3~)~3~·5H~2~O (99.99%, Aldrich, 0.1125 g), and polyvinylpyrrolidone (PVP) (Mw = 55, 000, Aldrich, 0.25 g) as surfactant. The reaction was triggered by rapid injection of 0.6 ml of hydroxylamine solution (NH~2~OH, 50% in H~2~O, Aldrich) at 140°C. Then, the reaction mixture turned brown red immediately, which indicated the formation of Bi~2~Se~3~ nanoplates. The reaction was allowed to process for 10 min for a complete reaction and cooled down to room temperature. The size and morphology of the Bi~2~Se~3~ nanoplates were characterized using transmission electron microscopy (JEM 1010, JEOL, Japan), at an accelerating voltage of 100 kV. X-ray diffraction (XRD) patterns were obtained by using an X-ray power diffraction meter (D/MAX-3C, Rigaku Co., Japan). UV-vis absorption spectra were measured using a TU-1950 UV-Vis spectrophotometer (Beijing Perkinje General Instrument Co., Ltd., Beijing, China) at room temperature.

Mice and cell lines
-------------------

Female Balb/c mice (weight about 20 g) were purchased from Shanghai SLAC Laboratory Animal Co. Ltd (Shanghai, China). Animal experiments and animal care were carried out according to protocols approved by the institutional committee for animal care, and also in accordance with the policy of the National Ministry of Health. Murine hepatocarcinoma cell line H22 was purchased from China Centre for Type Culture Collection (CCTCC, Wuhan, China), and cultured according to the guidelines given.

Cellular uptake efficiency and cytotoxicity assessment
------------------------------------------------------

In a typical experiment, H22 cells (1 × 10^4^ cells per well) were seeded in 96-well plates and incubated overnight at 37°C in a humidified 5% CO~2~ atmosphere. The cells were incubated with 100 μl of varying concentration of Bi~2~Se~3~ nanoplates prepared above for 24 h at 37°C in the dark under the same conditions. Cell viability was determined by the standard 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) (Aldrich) assay. In some cases, cells were collected and digested in HNO~3~ (65%) for 24 h, and then diluted in Milli-Q water for ICP-MS (7500CE, Agilent Technologies, USA) analysis.

CT imaging in vitro
-------------------

The solution of Bi~2~Se~3~ nanoplates with different concentrations in the range from 0 to 0.0488 mol Bi l^−1^ was directly detected using a 320-detector row scanner (Aquilion ONE; Toshiba Medical Systems, Japan) with the following operating parameters: thickness, 0.5 mm; pitch, 0.5 mm; tube voltage 120 KV; tube current, 50 mA; field of view, 350 mm. CT values were acquired on the same workstation using the software supplied by the manufacturer. Each experiment was carried out in triplicate.

0, 0.02 and 0.05 mol Bi l^−1^ were incubated with H22 cells (1 × 10^6^ cells per well) for 24 h at 37°C under 5% CO~2~. After washing with PBS for three times, H22 cells containing Bi~2~Se~3~ nanoplates in PBS were precipitated at the bottom of the tube for CT imaging.

CT imaging in vivo
------------------

100 μl of 1 × 10^6^ H22 cells (Balb/c background) in PBS was injected into left axilla region of female Balb/c mice. Mice were anesthetized during the CT imaging with 100 μl 20% urethane. CT scanning was performed both before and after intratumoral injection of Bi~2~Se~3~ nanoplates (100 μl, 0.2 mol Bi l^−1^). The mice were scanned by CT after 30 min and 120 min post-injection. As control, CT scanning was performed both before and after intratumoral injection of Iopamidol (100 μl, 0.2 mol I l^−1^). The mice were scanned by CT after 3 min and 60 min post-injection. All CT scans were performed using the above CT system.

In vitro photothermal therapy effects
-------------------------------------

An optical fiber coupled 808 nm high power diode-laser (Hi-Tech Optoelectronics Co., Ltd. Beijing, China) was used in the experiments. To study the photothermal effect induced by the NIR absorption, 1 ml aqueous solutions containing different concentration (0, 5, 10, 20 and 50 μg ml^−1^) of Bi~2~Se~3~ nanoplates were irradiated by a NIR laser (808 nm, 1 W) for 5 min. The temperatures of the solutions were monitored by a thermocouple microprobe (ϕ = 0.5 mm) submerged in the solution in a 1-cm square cuvette. The probe was placed at such a position that the direct irradiation of the laser on the probe was avoided.

For the cell toxicity assay, H22 cells were precultured in 96-well cell culture plates (1 × 10^4^ cells per well) for 24 h and then added with Bi~2~Se~3~ nanoplates at a series of concentrations. After incubation for 24 h, cells were rinsed with PBS and then were irradiated by the 808 nm laser at a power density of 1 W cm^−2^ for 5 min. After 24 h incubation, the standard MTT (Sigma) assay was carried out to determine the cell viabilities relative to the control untreated cells (incubated with the same volume of PBS).

In vivo photothermal therapy effects
------------------------------------

The H22 tumor models were generated by subcutaneous injection of 1 × 10^6^ H22 cells (Balb/c background) in PBS on the right rear flank of each mouse. The Bi~2~Se~3~ nanoplates were injected to the mice when the tumor volumes approached about 100 mm^3^. For photothermal treatment, the mice of each group were intratumorally injected with 100 μl of each solution (1 mg ml^−1^ Bi~2~Se~3~ nanoplates solution or sterile water) and immediately irradiated with continuous NIR laser to tumor region for 5 min at the power density of 2 Wcm^−2^. The tumor sizes were measured by a caliper every other day and were calculated using the equation (1): volume = ab^2^/2, where a is the maximum diameter of tumor and b is the minimum diameter of tumor. Relative tumor volumes were calculated as V/V~0~ (V~0~ is the tumor volume when the treatment was initiated).
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![Schematic representation of topological insulator bismuth selenide as a theranostic platform.\
Bismuth selenide is able to perform for simultaneous X-ray CT imaging and photothermal therapy.](srep01998-f1){#f1}

![Characterization of Bi~2~Se~3~ nanoplates.\
(a) TEM image and (b) XRD pattern of Bi~2~Se~3.~](srep01998-f2){#f2}

![Cell cytotoxicity and cell internalization of nanoplates.\
(a) Cell viability of H22 cells after incubation with increased concentration of Bi~2~Se~3~ nanoplates. (b) ICP-MS results of H22 cells incubated with Bi~2~Se~3~ nanoplates at 37°C and 4°C. Error bars correspond to mean ± standard deviations.](srep01998-f3){#f3}

![Results of X-ray CT imaging in vitro and in vivo.\
(a) In vitro CT images of Bi~2~Se~3~ nanoplates and Iopamidol with different concentrations. Cell analysis: H22 cells incubated without contrast agent (1), with increased concentration of Bi~2~Se~3~ nanoplates (0.02 and 0.05 mol Bi l^-1^ for 2 and 3, respectively). (b) CT value (HU) of Bi~2~Se~3~ nanoplates () or Iopamidol () as function of the concentration. (c) CT coronal views of a mouse following an intratumoral injection of 100 μl of Bi~2~Se~3~ nanoplates solution (0.2 mol Bi l^−1^) (top). The corresponding 3D rendering of in vivo CT images above (bottom). The position of tumor is marked by red circles.](srep01998-f4){#f4}

![Photothermal therapy in *in vitro* and *in vivo* system.\
(a) Photothermal effect of pure water and Bi~2~Se~3~ nanoplates with different concentrations (a--e: 0, 5, 10, 20, 50 μg ml^−1^) upon the irradiation of 1 W cm^−2^ 808 nm laser. (b) H22 cell viabilities cultured with Bi~2~Se~3~ nanoplates at different concentrations with or without laser irradiation. (c) Growth of H22 tumors in different groups of mice after treatment. The relative tumor volumes were normalized to their initial sizes. (d) Representative photos of a Bi~2~Se~3~ nanoplates-injected mouse at day 0 before PTT treatment and at day 20 after treatment. Error bars correspond to mean ± standard deviations.](srep01998-f5){#f5}
